Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 Alone or With Naproxen in Knee Osteoarthritis
NCT01102660Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2010
- Primary completion
- Feb 2011
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PH-797804 in osteoarthritis (OA) (4 arms), sponsored by Pfizer. Primary endpoint: Western Ontario & McMaster Osteoarthritis Index Pain Score at 2 weeks. Started May 2010; status: completed.
02
Drugs
PH-797804
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01102660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102660.